Analyst Group has interviewed Vistin Pharma’s CEO Magnus Tolleshaug and CFO Alexander Karlsen. In the interview they explain where the company is today, the focus going forward and gives three reasons as to why Vistin Pharma is a good investment today.

Read the interview here

About Analyst Group: One of Sweden's fastest growing equity research boutiques with a focus on small and medium-sized listed companies.
Read more about Analyst Group (Swedish)

This is a press release from Analyst Group regarding the publication of an interview with Vistin Pharma.